CG Oncology, Inc. Common stock
CGONNASDAQHealthcare● Active
$54.12
+$0.40(+0.75%)
Market Cap$4.8B
P/E Ratio—
52W High$75.5
52W Low$23.65
CG Oncology, Inc. Common stock（CGON）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CGON · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $4.04M | $1.14M | $0.20M | $0.19M | $10.36M |
| Cost of Revenue | $4.65M | $0.00M | $0.00M | $0.01M | $0.01M |
| Gross Profit | ($0.61M) | $1.14M | $0.20M | $0.18M | $10.35M |
| Gross Margin %(computed) | -15.02% | 100.00% | 100.00% | 92.15% | 99.90% |
| Operating Expenses | |||||
| R&D Expenses | $116.64M | $82.10M | $45.75M | $29.03M | $18.32M |
| G&A Expenses | $73.53M | $33.70M | $9.90M | $6.41M | $4.64M |
| Total Operating Expenses | $190.17M | $115.81M | $55.65M | $35.42M | $22.95M |
| Operating Income | ($190.77M) | ($114.67M) | ($55.45M) | ($35.25M) | ($12.61M) |
| Operating Margin %(computed) | — | — | — | — | -121.70% |
| Interest Income | $0.00M | $26.62M | $6.90M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.45M |
| Income Before Tax | ($161.00M) | ($88.04M) | ($48.61M) | ($35.44M) | ($12.84M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($161.00M) | ($88.04M) | ($48.61M) | ($35.44M) | ($12.84M) |
| Net Margin %(computed) | — | — | — | — | -123.95% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.08 | $-1.41 | $-1.02 | $-0.66 | $-0.28 |
| Wtd Avg Shares | 77.30M | 62.50M | 66.64M | 66.64M | 66.64M |
| EBITDA | ($159.55M) | ($114.63M) | ($55.43M) | ($35.23M) | ($12.38M) |
| EBITDA Margin %(computed) | — | — | — | — | -119.50% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解CG Oncology, Inc. Common stock
关于CG Oncology, Inc. Common stock（CGON）损益表
CG Oncology, Inc. Common stock（CGON）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CGON实现营收$0.00B，毛利润($0.00B)（毛利率-15.02%），净利润($0.16B)（净利率-3985.02%）。
常见问题
CGON · 4 问CG Oncology, Inc. Common stock（CGON）2025财年营收为$0.00B，同比up254.7%。
CGON revenueCGON salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08